Stifel analyst Tom Stephan assumes coverage on Clearpoint Neuro Inc. (NASDAQ: CLPT) with a Buy rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage